Challenges and opportunities for Aotearoa/New Zealand’s breast screening programme

Cover of Journal of the Royal Society of New Zealand

18 Feb 2025

 Lawrenson et al.

Around 3500 New Zealand women will be diagnosed with breast cancer each year. Of these, 45% will be diagnosed through mammography screening, either through BreastScreen Aotearoa or through the private sector. Those diagnosed through screening have better outcomes and importantly more equitable outcomes for Māori and Pacific women. With the advent of many technological changes, there are opportunities to increase the proportion of women who are diagnosed early through systematic screening and thus improve overall mortality from breast cancer. This article discusses the potential opportunities including widening the screening age and addressing the differences in screening rates for Māori and other ethnicities. The review also discusses potential changes to the screening modality (mammography), the value of grading breast density and the use of personalised screening. Finally, the article addresses the potential uses of Artificial Intelligence in assessing risk of cancer and in improving diagnostic accuracy of mammography.

Read more

Other stories

Academic LiteratureDrugs, devices and diagnostics
Cover Health Policy Journal
The development of a discrete choice experiment: Investigating pharmacy selection in New Zealand

The development of a discrete choice experiment: Investigating pharmacy selection in New Zealand

Discrete choice experiments (DCEs) provide a method for understanding preferences for service provision and there have been limited applications to the selection of community pharmacies. The validity and accuracy of DCEs rely upon the attributes and levels used. This paper aims to describe the development of a DCE investigating New Zealanders preferences for community pharmacies.

Key issues

HEALTH SERVICES AND SYSTEMS

Covering developments in the provision, funding and organisation of health care services.

EQUITY

Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.

DRUGS, DEVICE AND DIAGNOSTICS

Covering prescription medicines and medical devices.

PUBLIC HEALTH

Focusing on efforts to promote health and prevent disease through social and economic interventions.

DIGITAL HEALTH

Exploring the potential digital transformation to provide a more connected and accessible health system.

TE TIRITI

Monitoring how the health reforms and the performance of the health sector uphold Te Tiriti obligations.